Shape Memory Medical completes enrolment in landmark AAA‑SHAPE pivotal trial
Shape Memory Medical recently announced that it has completed enrolment in the AAA‑SHAPE pivotal trial. This is a prospective, multicentre, randomised, open‑label controlled study...
US FDA approves labelling update reflecting evidence in ruptured AAA for two Gore Excluder...
Gore today announced that the US Food and Drug Administration (FDA) has approved updated labelling for the Gore Excluder abdominal aortic aneurysm (AAA) endoprosthesis...
First commercial procedure performed using aXess vascular access device
Xeltis has announced the official start of the European commercialisation of aXess, marked by the successful treatment of the first commercial patient by Dominik...
First patient enrolled in study of retrievable scaffold system in complex CLTI cohorts
Reflow Medical has announced that the Medical University of Graz (Graz, Austria) has enrolled the first patient in the DEEPER CHALLENGE clinical trial.
The investigator-initiated,...
